- Home
- ZCMD vs FGEN Comparison
ZCMD vs FGEN Comparison
Compare ZCMD & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- FGEN
- Stock Information
- Founded
- ZCMD 2012
- FGEN 1993
- Country
- ZCMD China
- FGEN United States
- Employees
- ZCMD N/A
- FGEN N/A
- Industry
- ZCMD Other Consumer Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- FGEN Health Care
- Exchange
- ZCMD Nasdaq
- FGEN Nasdaq
- Market Cap
- ZCMD 29.0M
- FGEN 33.5M
- IPO Year
- ZCMD 2020
- FGEN 2014
- Fundamental
- Price
- ZCMD $1.16
- FGEN $7.26
- Analyst Decision
- ZCMD
- FGEN Strong Buy
- Analyst Count
- ZCMD 0
- FGEN 1
- Target Price
- ZCMD N/A
- FGEN $250.00
- AVG Volume (30 Days)
- ZCMD 597.6K
- FGEN 74.1K
- Earning Date
- ZCMD 01-01-0001
- FGEN 08-05-2025
- Dividend Yield
- ZCMD N/A
- FGEN N/A
- EPS Growth
- ZCMD N/A
- FGEN N/A
- EPS
- ZCMD N/A
- FGEN N/A
- Revenue
- ZCMD $15,864,773.00
- FGEN $6,996,000.00
- Revenue This Year
- ZCMD N/A
- FGEN N/A
- Revenue Next Year
- ZCMD N/A
- FGEN N/A
- P/E Ratio
- ZCMD N/A
- FGEN N/A
- Revenue Growth
- ZCMD N/A
- FGEN N/A
- 52 Week Low
- ZCMD $0.95
- FGEN $4.50
- 52 Week High
- ZCMD $2.97
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- ZCMD 46.90
- FGEN 60.54
- Support Level
- ZCMD $1.12
- FGEN $5.37
- Resistance Level
- ZCMD $1.24
- FGEN $5.73
- Average True Range (ATR)
- ZCMD 0.13
- FGEN 0.49
- MACD
- ZCMD -0.01
- FGEN 0.27
- Stochastic Oscillator
- ZCMD 16.03
- FGEN 83.80
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.